Apollo’s Covis sues over preterm-birth drug patents
05-01-2021
A US court has rejected attempts by two companies to market generic versions of a birth control pill owned by pharmaceutical company Actavis.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
ANDA, patent, Actavis, Lupin Pharmaceuticals, Amneal Pharmaceuticals
